<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2023//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_230101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">31949214</PMID><DateCompleted><Year>2020</Year><Month>11</Month><Day>16</Day></DateCompleted><DateRevised><Year>2021</Year><Month>01</Month><Day>15</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">2045-2322</ISSN><JournalIssue CitedMedium="Internet"><Volume>10</Volume><Issue>1</Issue><PubDate><Year>2020</Year><Month>Jan</Month><Day>16</Day></PubDate></JournalIssue><Title>Scientific reports</Title><ISOAbbreviation>Sci Rep</ISOAbbreviation></Journal><ArticleTitle>Microendoscopy detects altered muscular contractile dynamics in a mouse model of amyotrophic lateral sclerosis.</ArticleTitle><Pagination><StartPage>457</StartPage><MedlinePgn>457</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">457</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1038/s41598-019-56555-z</ELocationID><Abstract><AbstractText>Amyotrophic lateral sclerosis (ALS) is a fatal disease involving motor neuron degeneration. Effective diagnosis of ALS and quantitative monitoring of its progression are crucial to the success of clinical trials. Second harmonic generation (SHG) microendoscopy is an emerging technology for imaging single motor unit contractions. To assess the potential value of microendoscopy for diagnosing and tracking ALS, we monitored motor unit dynamics in a B6.SOD1G93A mouse model of ALS for several weeks. Prior to overt symptoms, muscle twitch rise and relaxation time constants both increased, consistent with a loss of fast-fatigable motor units. These effects became more pronounced with disease progression, consistent with the death of fast fatigue-resistant motor units and superior survival of slow motor units. From these measurements we constructed a physiological metric that reflects the changing distributions of measured motor unit time constants and effectively diagnoses mice before symptomatic onset and tracks disease state. These results indicate that SHG microendoscopy provides a means for developing a quantitative, physiologic characterization of ALS progression.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Chen</LastName><ForeName>Xuefeng</ForeName><Initials>X</Initials><AffiliationInfo><Affiliation>Department of Mechanical Engineering, Stanford University, Stanford, CA, 94305, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sanchez</LastName><ForeName>Gabriel N</ForeName><Initials>GN</Initials><AffiliationInfo><Affiliation>Department of Bioengineering, Stanford University, Stanford, CA, 94305, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Enspectra Health, Mountain View, CA, 94040, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Schnitzer</LastName><ForeName>Mark J</ForeName><Initials>MJ</Initials><AffiliationInfo><Affiliation>Department of Biology, Stanford University, Stanford, CA, 94305, USA. schnitzer@stanford.edu.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Applied Physics, Stanford University, Stanford, CA, 94305, USA. schnitzer@stanford.edu.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Howard Hughes Medical Institute, Stanford University, Stanford, CA, 94305, USA. schnitzer@stanford.edu.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Delp</LastName><ForeName>Scott L</ForeName><Initials>SL</Initials><AffiliationInfo><Affiliation>Department of Mechanical Engineering, Stanford University, Stanford, CA, 94305, USA. delp@stanford.edu.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Bioengineering, Stanford University, Stanford, CA, 94305, USA. delp@stanford.edu.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2020</Year><Month>01</Month><Day>16</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Sci Rep</MedlineTA><NlmUniqueID>101563288</NlmUniqueID><ISSNLinking>2045-2322</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000690" MajorTopicYN="N">Amyotrophic Lateral Sclerosis</DescriptorName><QualifierName UI="Q000000981" MajorTopicYN="Y">diagnostic imaging</QualifierName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName><QualifierName UI="Q000503" MajorTopicYN="Y">physiopathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002452" MajorTopicYN="N">Cell Count</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D004195" MajorTopicYN="N">Disease Models, Animal</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D004724" MajorTopicYN="Y">Endoscopy</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D051379" MajorTopicYN="N">Mice</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009046" MajorTopicYN="N">Motor Neurons</DescriptorName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D009119" MajorTopicYN="Y">Muscle Contraction</DescriptorName></MeshHeading></MeshHeadingList><CoiStatement>G.N.S., S.L.D. and M.J.S. have co-founded Enspectra Health, Inc. to disseminate the imaging technology described here and have a financial interest in the company.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2019</Year><Month>9</Month><Day>10</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2019</Year><Month>12</Month><Day>7</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2020</Year><Month>1</Month><Day>18</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2020</Year><Month>1</Month><Day>18</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2020</Year><Month>11</Month><Day>18</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">31949214</ArticleId><ArticleId IdType="pmc">PMC6965652</ArticleId><ArticleId IdType="doi">10.1038/s41598-019-56555-z</ArticleId><ArticleId IdType="pii">10.1038/s41598-019-56555-z</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Rowland LP, Shneider NA. Amyotriphic Lateral Sclerosis. N. Engl. J. Med. 2001;344:1688&#x2013;1700. doi: 10.1056/NEJM200105313442207.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJM200105313442207</ArticleId><ArticleId IdType="pubmed">11386269</ArticleId></ArticleIdList></Reference><Reference><Citation>Miller, R. G., Mitchell, J. D. &amp; Moore, D. H. Riluzole for amyotrophic lateral sclerosis (ALS)/motor neuron disease (MND). Cochrane Database Syst. Rev., CD001447 (2012).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7055506</ArticleId><ArticleId IdType="pubmed">22419278</ArticleId></ArticleIdList></Reference><Reference><Citation>Petrov D, Mansfield C, Moussy A, Hermine O. AALS clinical trials review: 20 years of failure. Are we any closer to registering a new treatment. Front. Aging Neurosci. 2017;9:1&#x2013;11. doi: 10.3389/fnagi.2017.00068.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fnagi.2017.00068</ArticleId><ArticleId IdType="pmc">PMC5360725</ArticleId><ArticleId IdType="pubmed">28382000</ArticleId></ArticleIdList></Reference><Reference><Citation>Rothstein JD. Edaravone: A new drug approved for ALS. Cell. 2017;171:725. doi: 10.1016/j.cell.2017.10.011.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2017.10.011</ArticleId><ArticleId IdType="pubmed">29100067</ArticleId></ArticleIdList></Reference><Reference><Citation>Gen&#xe7; B, &#xd6;zdinler PH. Moving forward in clinical trials for ALS: motor neurons lead the way please. Drug Discov. Today. 2014;19:441&#x2013;449. doi: 10.1016/j.drudis.2013.10.014.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.drudis.2013.10.014</ArticleId><ArticleId IdType="pmc">PMC4000750</ArticleId><ArticleId IdType="pubmed">24171950</ArticleId></ArticleIdList></Reference><Reference><Citation>Cedarbaum JM, et al. The ALSFRS-R: a revised ALS functional rating scale that incorporates assessments of respiratory function. J. Neurol. Sci. 1999;169:13&#x2013;21. doi: 10.1016/S0022-510X(99)00210-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0022-510X(99)00210-5</ArticleId><ArticleId IdType="pubmed">10540002</ArticleId></ArticleIdList></Reference><Reference><Citation>Franchignoni F, Mandrioli J, Giordano A, Ferro S. A further Rasch study confirms that ALSFRS-R does not conform to fundamental measurement requirements. Amyotroph. Lateral Scler. Front. Degener. 2015;8421:1&#x2013;7.</Citation><ArticleIdList><ArticleId IdType="pubmed">25916346</ArticleId></ArticleIdList></Reference><Reference><Citation>Sanchez GN, et al. In vivo imaging of human sarcomere twitch dynamics in individual motor units. Neuron. 2015;88:1109&#x2013;1120. doi: 10.1016/j.neuron.2015.11.022.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuron.2015.11.022</ArticleId><ArticleId IdType="pmc">PMC5920519</ArticleId><ArticleId IdType="pubmed">26687220</ArticleId></ArticleIdList></Reference><Reference><Citation>Frey D, et al. Early and selective loss of neuromuscular synapse subtypes with low sprouting competence in motoneuron diseases. J. Neurosci. 2000;20:2534&#x2013;2542. doi: 10.1523/JNEUROSCI.20-07-02534.2000.</Citation><ArticleIdList><ArticleId IdType="doi">10.1523/JNEUROSCI.20-07-02534.2000</ArticleId><ArticleId IdType="pmc">PMC6772256</ArticleId><ArticleId IdType="pubmed">10729333</ArticleId></ArticleIdList></Reference><Reference><Citation>Pun S, Santos AF, Saxena S, Xu L, Caroni P. Selective vulnerability and pruning of phasic motoneuron axons in motoneuron disease alleviated by CNTF. Nat. Neurosci. 2006;9:408&#x2013;419. doi: 10.1038/nn1653.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nn1653</ArticleId><ArticleId IdType="pubmed">16474388</ArticleId></ArticleIdList></Reference><Reference><Citation>Hegedus J, Putman CT, Tyreman N, Gordon T. Preferential motor unit loss in the SOD1 G93A transgenic mouse model of amyotrophic lateral sclerosis. J. Physiol. 2008;586:3337&#x2013;3351. doi: 10.1113/jphysiol.2007.149286.</Citation><ArticleIdList><ArticleId IdType="doi">10.1113/jphysiol.2007.149286</ArticleId><ArticleId IdType="pmc">PMC2538809</ArticleId><ArticleId IdType="pubmed">18467368</ArticleId></ArticleIdList></Reference><Reference><Citation>Gurney ME, et al. Motor neuron degeneration in mice that express a human Cu,Zn superoxide dismutase mutation. Science (80-). 1994;264:1772&#x2013;1775. doi: 10.1126/science.8209258.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.8209258</ArticleId><ArticleId IdType="pubmed">8209258</ArticleId></ArticleIdList></Reference><Reference><Citation>Kugelberg E, Edstr&#xf6;m L, Abbruzzese M. Mapping of motor units in experimentally reinnervated rat muscle. Interpretation of histochemical and atrophic fibre patterns in neurogenic lesions. J. Neurol. Neurosurg. Psychiatry. 1970;33:319&#x2013;329. doi: 10.1136/jnnp.33.3.319.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/jnnp.33.3.319</ArticleId><ArticleId IdType="pmc">PMC493476</ArticleId><ArticleId IdType="pubmed">4246999</ArticleId></ArticleIdList></Reference><Reference><Citation>Fawcett T. An introduction to ROC analysis. Pattern Recognit. Lett. 2006;27:861&#x2013;874. doi: 10.1016/j.patrec.2005.10.010.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.patrec.2005.10.010</ArticleId></ArticleIdList></Reference><Reference><Citation>Burkholder TJ, Fingado B, Baron S, Lieber RL. Relationship between muscle fiber types and sizes and muscle architectural properties in the mouse hindlimb. J. Morphol. 1994;221:177&#x2013;190. doi: 10.1002/jmor.1052210207.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jmor.1052210207</ArticleId><ArticleId IdType="pubmed">7932768</ArticleId></ArticleIdList></Reference><Reference><Citation>Bateson, D. &amp; Parry, D. Motor units in a fast-twitch muscle of normal and dystrophic mice. J. Physiol. 345, 515&#x2013;523 (1983).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1193812</ArticleId><ArticleId IdType="pubmed">6663510</ArticleId></ArticleIdList></Reference><Reference><Citation>Lewis DM, Parry DJ, Rowlerson A. Isometric contractions of motor units and immunohistochemistry of mouse soleus muscle. J. Physiol. 1982;325:393&#x2013;401. doi: 10.1113/jphysiol.1982.sp014157.</Citation><ArticleIdList><ArticleId IdType="doi">10.1113/jphysiol.1982.sp014157</ArticleId><ArticleId IdType="pmc">PMC1251401</ArticleId><ArticleId IdType="pubmed">7050345</ArticleId></ArticleIdList></Reference><Reference><Citation>Kry&#x15b;ciak K, Grieb P, Celichowski J. Changes in motor unit properties in SOD1 (G93A) rats. Muscle Nerve. 2014;50:577&#x2013;586. doi: 10.1002/mus.24196.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/mus.24196</ArticleId><ArticleId IdType="pubmed">24488615</ArticleId></ArticleIdList></Reference><Reference><Citation>Hegedus J, Putman CT, Gordon T. Time course of preferential motor unit loss in the SOD1G93A mouse model of amyotrophic lateral sclerosis. Neurobiol. Dis. 2007;28:154&#x2013;164. doi: 10.1016/j.nbd.2007.07.003.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.nbd.2007.07.003</ArticleId><ArticleId IdType="pubmed">17766128</ArticleId></ArticleIdList></Reference><Reference><Citation>Pellegrino C, Franzini C. An Electron Microscope Study of Denervation Atrophy in Red and White Skeletal Muscle Fibers. J. Cell Biol. 1963;17:327&#x2013;349. doi: 10.1083/jcb.17.2.327.</Citation><ArticleIdList><ArticleId IdType="doi">10.1083/jcb.17.2.327</ArticleId><ArticleId IdType="pmc">PMC2106209</ArticleId><ArticleId IdType="pubmed">19866627</ArticleId></ArticleIdList></Reference><Reference><Citation>Raikova R, Krutki P, Aladjov H, Celichowski J. Variability of the twitch parameters of the rat medial gastrocnemius motor units&#x2014;experimental and modeling study. Comput. Biol. Med. 2007;37:1572&#x2013;1581. doi: 10.1016/j.compbiomed.2007.02.006.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.compbiomed.2007.02.006</ArticleId><ArticleId IdType="pubmed">17442297</ArticleId></ArticleIdList></Reference><Reference><Citation>Hayworth CR, Gonzalez-Lima F. Pre-symptomatic detection of chronic motor deficits and genotype prediction in congenic B6.SOD1G93A ALS mouse model. Neuroscience. 2009;164:975&#x2013;985. doi: 10.1016/j.neuroscience.2009.08.031.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuroscience.2009.08.031</ArticleId><ArticleId IdType="pmc">PMC2783710</ArticleId><ArticleId IdType="pubmed">19699279</ArticleId></ArticleIdList></Reference><Reference><Citation>Wooley CM, et al. Gait analysis detects early changes in transgenic SOD1(G93A) mice. Muscle Nerve. 2005;32:43&#x2013;50. doi: 10.1002/mus.20228.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/mus.20228</ArticleId><ArticleId IdType="pmc">PMC1350398</ArticleId><ArticleId IdType="pubmed">15880561</ArticleId></ArticleIdList></Reference><Reference><Citation>Shefner JM, Cudkowicz ME, Brown RH. Comparison of incremental with multipoint MUNE methods in transgenic ALS mice. Muscle Nerve. 2002;25:39&#x2013;42. doi: 10.1002/mus.10000.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/mus.10000</ArticleId><ArticleId IdType="pubmed">11754183</ArticleId></ArticleIdList></Reference><Reference><Citation>Dibaj P, Schomburg ED, Steffens H. Contractile characteristics of gastrocnemius-soleus muscle in the SOD1G93A ALS mouse model. Neurol. Res. 2015;37:693&#x2013;702. doi: 10.1179/1743132815Y.0000000039.</Citation><ArticleIdList><ArticleId IdType="doi">10.1179/1743132815Y.0000000039</ArticleId><ArticleId IdType="pubmed">25917373</ArticleId></ArticleIdList></Reference><Reference><Citation>Tian F, et al. Monitoring peripheral nerve degeneration in ALS by label-free stimulated Raman scattering imaging. Nat. Commun. 2016;7:13283. doi: 10.1038/ncomms13283.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/ncomms13283</ArticleId><ArticleId IdType="pmc">PMC5095598</ArticleId><ArticleId IdType="pubmed">27796305</ArticleId></ArticleIdList></Reference><Reference><Citation>Ly CV, Miller TM. Emerging antisense oligonucleotide and viral therapies for amyotrophic lateral sclerosis. Curr. Opin. Neurol. 2018;31:648&#x2013;654. doi: 10.1097/WCO.0000000000000594.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/WCO.0000000000000594</ArticleId><ArticleId IdType="pmc">PMC7291817</ArticleId><ArticleId IdType="pubmed">30028737</ArticleId></ArticleIdList></Reference><Reference><Citation>Maier M, et al. A human-derived antibody targets misfolded SOD1 and ameliorates motor symptoms in mouse models of amyotrophic lateral sclerosis. Sci. Transl. Med. 2018;10:eaah3924. doi: 10.1126/scitranslmed.aah3924.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/scitranslmed.aah3924</ArticleId><ArticleId IdType="pubmed">30518612</ArticleId></ArticleIdList></Reference><Reference><Citation>Benatar M, et al. ALS biomarkers for therapy development: state of the field &amp; future directions. Muscle Nerve. 2016;53:169&#x2013;182. doi: 10.1002/mus.24979.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/mus.24979</ArticleId><ArticleId IdType="pmc">PMC4718795</ArticleId><ArticleId IdType="pubmed">26574709</ArticleId></ArticleIdList></Reference><Reference><Citation>Verber NS, et al. Biomarkers in Motor Neuron Disease: A State of the Art Review. Front. Neurol. 2019;10:1&#x2013;28. doi: 10.3389/fneur.2019.00291.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fneur.2019.00291</ArticleId><ArticleId IdType="pmc">PMC6456669</ArticleId><ArticleId IdType="pubmed">31001186</ArticleId></ArticleIdList></Reference><Reference><Citation>Gooch CL, et al. Motor unit number estimation: A technology and literature review. Muscle Nerve. 2014;50:884&#x2013;893. doi: 10.1002/mus.24442.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/mus.24442</ArticleId><ArticleId IdType="pubmed">25186553</ArticleId></ArticleIdList></Reference><Reference><Citation>Strong MJ, Brown WF, Hudson AJ, Snow R. Motor unit estimates in the biceps-brachialis in amyotrophic lateral sclerosis. Muscle Nerve. 1988;11:415&#x2013;422. doi: 10.1002/mus.880110502.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/mus.880110502</ArticleId><ArticleId IdType="pubmed">3374513</ArticleId></ArticleIdList></Reference><Reference><Citation>Rutkove SB, et al. Electrical impedance myography correlates with standard measures of ALS severity. Muscle Nerve. 2014;49:441&#x2013;443. doi: 10.1002/mus.24128.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/mus.24128</ArticleId><ArticleId IdType="pubmed">24273034</ArticleId></ArticleIdList></Reference><Reference><Citation>Geevasinga N, et al. Awaji criteria improves the diagnostic sensitivity in amyotrophic lateral sclerosis: a systematic review using individual patient data. Clin. Neurophysiol. 2016;127:2684&#x2013;2691. doi: 10.1016/j.clinph.2016.04.005.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.clinph.2016.04.005</ArticleId><ArticleId IdType="pubmed">27212114</ArticleId></ArticleIdList></Reference><Reference><Citation>Johnson MA, Polgar J, Weightman D, Appleton D. Data on the distribution of fibre types in thirty-six human muscles: An autopsy study. J. Neurol. Sci. 1973;18:111&#x2013;129. doi: 10.1016/0022-510X(73)90023-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/0022-510X(73)90023-3</ArticleId><ArticleId IdType="pubmed">4120482</ArticleId></ArticleIdList></Reference><Reference><Citation>Botev ZI, Grotowski JF, Kroese DP. Kernel density estimation via diffusion. Ann. Stat. 2010;38:2916&#x2013;2957. doi: 10.1214/10-AOS799.</Citation><ArticleIdList><ArticleId IdType="doi">10.1214/10-AOS799</ArticleId></ArticleIdList></Reference><Reference><Citation>Schiaffino S, et al. Three myosin heavy chain isoforms in type 2 skeletal muscle fibres. J. Muscle Res. Cell Motil. 1989;10:197&#x2013;205. doi: 10.1007/BF01739810.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/BF01739810</ArticleId><ArticleId IdType="pubmed">2547831</ArticleId></ArticleIdList></Reference><Reference><Citation>Lucas CA, Kang LHD, Hoh JFY. Monospecific antibodies against the three mammalian fast limb myosin heavy chains. Biochem. Biophys. Res. Commun. 2000;272:303&#x2013;308. doi: 10.1006/bbrc.2000.2768.</Citation><ArticleIdList><ArticleId IdType="doi">10.1006/bbrc.2000.2768</ArticleId><ArticleId IdType="pubmed">10872844</ArticleId></ArticleIdList></Reference><Reference><Citation>Schindelin, J. et al. Fiji: an open-source platform for biological-image analysis. 9 (2012).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3855844</ArticleId><ArticleId IdType="pubmed">22743772</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>